RenovoRx (RNXT)
Develops targeted intra-arterial chemotherapy and commercializes the RenovoCath delivery device.
$2.65
Pre-market+0.13 (+5.37%)
At close$2.51(+18.96%)
Something off on this page? Send us feedback.
Next report
Nov 12, 2026
in 70 days
EPS estimate
−$0.05
Revenue estimate
$1.1M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.12−$0.08−$0.08−$0.08−$0.08−$0.08−$0.05Pending
Estimate−$0.13−$0.08−$0.08−$0.08−$0.08−$0.08−$0.07−$0.05
Surprise+7.7%0.0%0.0%0.0%0.0%0.0%+31.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$43.0K$197.0K$422.0K$266.0K$238.0K$563.0K$909.0KPending
Estimate$167.5K$183.3K$304.0K$405.4K$419.7K$469.5K$703.8K$1.1M
Surprise−74.3%+7.5%+38.8%−34.4%−43.3%+19.9%+29.2%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.05 | — | — |
| Aug 2026 | −$0.07 | −$0.05 | +31.0% |
| May 2026 | −$0.08 | −$0.08 | 0.0% |
| Mar 2026 | −$0.08 | −$0.08 | 0.0% |
| Nov 2025 | −$0.08 | −$0.08 | 0.0% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.05 | — | — | $1.1M | — | — | — |
| Aug 12, 2026 | −$0.07 | −$0.05 | +31.0% | $703.8K | $909.0K | +29.2% | +12.5% |
| May 14, 2026 | −$0.08 | −$0.08 | 0.0% | $469.5K | $563.0K | +19.9% | −4.1% |
| Mar 30, 2026 | −$0.08 | −$0.08 | 0.0% | $419.7K | $238.0K | −43.3% | −5.6% |
| Nov 13, 2025 | −$0.08 | −$0.08 | 0.0% | $405.4K | $266.0K | −34.4% | −23.0% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 10, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 16, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 2, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 30, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 27, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||